6-minute walking test: a useful tool in the management of heart failure patients

Sophia Giannitsi, Mara Bougiakli, Aris Bechlioulis, Anna Kotsia, Lampros K Michalis, Katerina K Naka, Sophia Giannitsi, Mara Bougiakli, Aris Bechlioulis, Anna Kotsia, Lampros K Michalis, Katerina K Naka

Abstract

Reduced functional ability and exercise tolerance in patients with heart failure (HF) are associated with poor quality of life and a worse prognosis. The 6-minute walking test (6MWT) is a widely available and well-tolerated test for the assessment of the functional capacity of patients with HF. Although the cardiopulmonary exercise test (a maximal exercise test) remains the gold standard for the evaluation of exercise capacity in patients with HF, the 6MWT (submaximal exercise test) may provide reliable information about the patient's daily activity. The current review summarizes the value of 6MWT in patients with HF and identifies its usefulness and limitations in everyday clinical practice in populations of HF. We aimed to investigate potential associations of 6MWD with other measures of functional status and determinants of 6MWD in patients with HF as well as to review its prognostic role and changes to various interventions in these patients.

Keywords: 6-minute walking test; functional capacity; heart failure; heart failure with reduced ejection fraction.

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

References

    1. Ponikowski P, Voors AA, Anker SDet al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J 2016; 37: 2129–2200.
    1. Guyatt GH, Sullivan MJ, Thompson PJet al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919–923.
    1. Alahdab MT, Mansour IN, Napan Set al. Six minute walk test predicts long-term all-cause mortality and heart failure rehospitalization in African-American patients hospitalized with acute decompensated heart failure. J Card Fail 2009; 15: 130–135.
    1. Guazzi M, Dickstein K, Vicenzi Met al. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights. Circ Heart Fail 2009; 2: 549–555.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111–117.
    1. Holland AE, Spruit MA, Troosters Tet al. An official European respiratory society/American thoracic society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 2014; 44: 1428–1446.
    1. Cheetham C, Taylor R, Burke Vet al. The 6-minute walk test does not reliably detect changes in functional capacity of patients awaiting cardiac transplantation. J Heart Lung Transplant 2005; 24: 848–853.
    1. Nixon PA, Joswiak ML, Fricker FJ. A six-minute walk test for assessing exercise tolerance in severely ill children. J Pediatr 1996; 129: 362–366.
    1. Hajiro T, Nishimura K, Tsukino Met al. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1185–1189.
    1. Zugck C, Kruger C, Durr Set al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 2000; 21: 540–549.
    1. Galie N, Humbert M, Vachiery JLet al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67–119.
    1. Bittner V, Weiner DH, Yusuf Set al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD investigators. JAMA 1993; 270: 1702–1707.
    1. Cahalin LP, Mathier MA, Semigran MJet al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996; 110: 325–332.
    1. Vitale G, Sarullo S, Vassallo Let al. Prognostic value of the 6-min walk test after open-heart valve surgery: experience of a cardiovascular rehabilitation program. J Cardiopulm Rehabil Prev 2018; 38: 304–308.
    1. O’Keeffe ST, Lye M, Donnellan Cet al. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998; 80: 377–382.
    1. Morales MN, Audag N, Caty Get al. Learning and encouragement effects on six-minute walking test in children. J Pediatr 2018; 198: 98–103.
    1. Spencer L, Zafiropoulos B, Denniss Wet al. Is there a learning effect when the 6-minute walk test is repeated in people with suspected pulmonary hypertension? Chron Respir Dis 2018; 1479972317752762.
    1. Uszko-Lencer N, Mesquita R, Janssen Eet al. Reliability, construct validity and determinants of 6-minute walk test performance in patients with chronic heart failure. Int J Cardiol 2017; 240: 285–290.
    1. Beriault K, Carpentier AC, Gagnon Cet al. Reproducibility of the 6-minute walk test in obese adults. Int J Sports Med 2009; 30: 725–727.
    1. Balashov K, Feldman DE, Savard Set al. Percent predicted value for the 6-minute walk test: using norm-referenced equations to characterize severity in persons with CHF. J Card Fail 2008; 14: 75–81.
    1. Enright PL. The six-minute walk test. Respir Care 2003; 48: 783–785.
    1. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384–1387.
    1. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14: 270–274.
    1. Gibbons WJ, Fruchter N, Sloan Set al. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 2001; 21: 87–93.
    1. Enright PL, McBurnie MA, Bittner Vet al. The 6-min walk test: a quick measure of functional status in elderly adults. Chest 2003; 123: 387–398.
    1. Chetta A, Zanini A, Pisi Get al. Reference values for the 6-min walk test in healthy subjects 20–50 years old. Respir Med 2006; 100: 1573–1578.
    1. Camarri B, Eastwood PR, Cecins NMet al. Six minute walk distance in healthy subjects aged 55–75 years. Respir Med 2006; 100: 658–665.
    1. Poh H, Eastwood PR, Cecins NMet al. Six-minute walk distance in healthy Singaporean adults cannot be predicted using reference equations derived from Caucasian populations. Respirology 2006; 11: 211–216.
    1. Masmoudi K, Aouicha MS, Fki Het al. The six minute walk test: which predictive values to apply for Tunisian subjects aged between 40 and 80 years?. Tunis Med 2008; 86: 20–26.
    1. Alameri H, Al-Majed S, Al-Howaikan A. Six-min walk test in a healthy adult Arab population. Respir Med 2009; 103: 1041–1046.
    1. Ben Saad H, Prefaut C, Tabka Zet al. 6-minute walk distance in healthy North Africans older than 40 years: influence of parity. Respir Med 2009; 103: 74–84.
    1. Iwama AM, Andrade GN, Shima Pet al. The six-minute walk test and body weight-walk distance product in healthy Brazilian subjects. Braz J Med Biol Res 2009; 42: 1080–1085.
    1. Casanova C, Celli BR, Barria Pet al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J 2011; 37: 150–156.
    1. Dourado VZ, Vidotto MC, Guerra RL. Reference equations for the performance of healthy adults on field walking tests. J Bras Pneumol 2011; 37: 607–614.
    1. Soaresa MR, Pereira CA. Six-minute walk test: reference values for healthy adults in Brazil. J Bras Pneumol 2011; 37: 576–583.
    1. Britto RR, Probst VS, de Andrade AFet al. Reference equations for the six-minute walk distance based on a Brazilian multicenter study. Braz J Phys Ther 2013; 17: 556–563.
    1. Duncan MJ, Mota J, Carvalho Jet al. An evaluation of prediction equations for the 6 minute walk test in healthy European adults aged 50–85 years. PLoS One 2015; 10: e0139629.
    1. Oliveira MJ, Marcoa R, Moutinho Jet al. Reference equations for the 6-minute walk distance in healthy Portuguese subjects 18–70 years old. Pulmonology. Epub ahead of print 3 July 2018. DOI: 10.1016/j.pulmoe.2018.04.003.
    1. Wegrzynowska-Teodorczyk K, Rudzinska E, Lazorczyk Met al. Distance covered during a six-minute walk test predicts long-term cardiovascular mortality and hospitalisation rates in men with systolic heart failure: an observational study. J Physiother 2013; 59: 177–187.
    1. Yap J, Lim FY, Gao Fet al. Correlation of the New York heart association classification and the 6-minute walk distance: a systematic review. Clin Cardiol 2015; 38: 621–628.
    1. Metra M, Ponikowski P, Dickstein Ket al. Advanced chronic heart failure: a position statement from the study group on advanced heart failure of the heart failure Association of the European Society of Cardiology. Eur J Heart Fail 2007; 9: 684–694.
    1. Roul G, Germain P, Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 1998; 136: 449–457.
    1. Lucas C, Stevenson LW, Johnson Wet al. The 6-min walk and peak oxygen consumption in advanced heart failure: aerobic capacity and survival. Am Heart J 1999; 138: 618–624.
    1. Rostagno C, Galanti G, Comeglio Met al. Comparison of different methods of functional evaluation in patients with chronic heart failure. Eur J Heart Fail 2000; 2: 273–280.
    1. Opasich C, Pinna GD, Mazza Aet al. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J 2001; 22: 488–496.
    1. Jehn M, Schmidt-Trucksass A, Schuster Tet al. Daily walking performance as an independent predictor of advanced heart failure: prediction of exercise capacity in chronic heart failure. Am Heart J 2009; 157: 292–298.
    1. Carvalho EE, Costa DC, Crescencio JCet al. Heart failure: comparison between six-minute walk test and cardiopulmonary test. Arq Bras Cardiol 2011; 97: 59–64.
    1. Deboeck G, Van Muylem A, Vachiery JLet al. Physiological response to the 6-minute walk test in chronic heart failure patients versus healthy control subjects. Eur J Prev Cardiol 2014; 21: 997–1003.
    1. Omar HR, Guglin M. The longitudinal relationship between six-minute walk test and cardiopulmonary exercise testing, and association with symptoms in systolic heart failure: analysis from the ESCAPE trial. Eur J Intern Med 2017; 40: e26–e28.
    1. Yoshimura K, Urabe Y, Maeda Net al. Dynamics of cardiorespiratory response during and after the six-minute walk test in patients with heart failure. Physiother Theory Pract 2018; 1–12.
    1. Forman DE, Fleg JL, Kitzman DWet al. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol 2012; 60: 2653–2661.
    1. Shah MR, Hasselblad V, Gheorghiade Met al. Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol 2001; 88: 987–993.
    1. Maldonado-Martin S, Brubaker PH, Eggebeen Jet al. Association between 6-minute walk test distance and objective variables of functional capacity after exercise training in elderly heart failure patients with preserved ejection fraction: a randomized exercise trial. Arch Phys Med Rehabil 2017; 98: 600–603.
    1. Curtis JP, Rathore SS, Wang Yet al. The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. J Card Fail 2004; 10: 9–14.
    1. Ingle L, Rigby AS, Nabb Set al. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. Eur J Heart Fail 2006; 8: 321–325.
    1. McCullough PA, Franklin BA, Leifer Eet al. Impact of reduced kidney function on cardiopulmonary fitness in patients with systolic heart failure. Am J Nephrol 2010; 32: 226–233.
    1. Vuckovic KM, Puzantian H. Estimated glomerular filtration rate and 6-minute walk distance in African Americans with mild to moderate heart failure. Cardiorenal Med 2017; 7: 227–233.
    1. Felker GM, Whellan D, Kraus WEet al. N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION) study. Am Heart J 2009; 158: S37–44.
    1. Gardin JM, Leifer ES, Fleg JLet al. Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. Am Heart J 2009; 158: S45–S52.
    1. Bajraktari G, Dini FL, Fontanive Pet al. Independent and incremental prognostic value of Doppler-derived left ventricular total isovolumic time in patients with systolic heart failure. Int J Cardiol 2011; 148: 271–275.
    1. Farag EM, Al-Daydamony MM, Gad MM. What is the association between left ventricular diastolic dysfunction and 6-minute walk test in hypertensive patients? J Am Soc Hypertens 2017; 11: 158–164.
    1. Wohlfahrt P, Melenovsky V, Redfield MMet al. Aortic waveform analysis to individualize treatment in heart failure. Circ Heart Fail 2017; 10: e003516.
    1. Arslan S, Erol MK, Gundogdu Fet al. Prognostic value of 6-minute walk test in stable outpatients with heart failure. Tex Heart Inst J 2007; 34: 166–169.
    1. Frankenstein L, Remppis A, Graham Jet al. Gender and age related predictive value of walk test in heart failure: do anthropometrics matter in clinical practice? Int J Cardiol 2008; 127: 331–336.
    1. Boxer R, Kleppinger A, Ahmad Aet al. The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure. Congest Heart Fail 2010; 16: 208–213.
    1. Woo MA, Moser DK, Stevenson LWet al. Six-minute walk test and heart rate variability: lack of association in advanced stages of heart failure. Am J Crit Care 1997; 6: 348–354.
    1. den Boer SL, Flipse DH, van der Meulen MHet al. Six-minute walk test as a predictor for outcome in children with dilated cardiomyopathy and chronic stable heart failure. Pediatr Cardiol 2017; 38: 465–471.
    1. Ingle L, Cleland JG, Clark AL. The relation between repeated 6-minute walk test performance and outcome in patients with chronic heart failure. Ann Phys Rehabil Med 2014; 57: 244–253.
    1. Ciani O, Piepoli M, Smart Net al. Validation of exercise capacity as a surrogate endpoint in exercise-based rehabilitation for heart failure: a meta-analysis of randomized controlled trials. JACC Heart Fail 2018; 6: 596–604.
    1. Ferreira JP, Duarte K, Graves TLet al. Natriuretic peptides, 6-min walk test, and quality-of-life questionnaires as clinically meaningful endpoints in HF trials. J Am Coll Cardiol 2016; 68: 2690–2707.
    1. McCabe N, Butler J, Dunbar SBet al. Six-minute walk distance predicts 30-day readmission after acute heart failure hospitalization. Heart Lung 2017; 46: 287–292.
    1. Howie-Esquivel J, Dracup K. Does oxygen saturation or distance walked predict rehospitalization in heart failure? J Cardiovasc Nurs 2008; 23: 349–356.
    1. Tager T, Hanholz W, Cebola Ret al. Minimal important difference for 6-minute walk test distances among patients with chronic heart failure. Int J Cardiol 2014; 176: 94–98.
    1. Corvera-Tindel T, Doering LV, Woo MAet al. Effects of a home walking exercise program on functional status and symptoms in heart failure. Am Heart J 2004; 147: 339–346.
    1. Palmer K, Bowles KA, Paton Met al. Chronic heart failure and exercise rehabilitation: a systematic review and meta-analysis. Arch Phys Med Rehabil. Epub ahead of print 24 April 2018. DOI: 10.1016/j.apmr.2018.03.015.
    1. Olsson LG, Swedberg K, Clark ALet al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005; 26: 778–793.
    1. Brenyo A, Goldenberg I, Moss AJet al. Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT. Heart Rhythm 2012; 9: 1454–1459.
    1. Beltran P, Palau P, Dominguez Eet al. Sacubitril/valsartan and short-term changes in the 6-minute walk test: a pilot study. Int J Cardiol 2018; 252: 136–139.
    1. Mirdamadi A, Arefeh A, Garakyaraghi Met al. Beneficial effects of the treatment of iron deficiency on clinical condition, left ventricular function, and quality of life in patients with chronic heart failure. Acta Biomed 2018; 89: 214–218.
    1. Gotzmann M, Hehen T, Germing Aet al. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart 2010; 96: 1102–1106.
    1. D’Ascenzo F, Moretti C, Marra WGet al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol 2015; 116: 325–331.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren